In this discussion, a US-based KOL speaks about current treatment trends, focusing on the safety and efficacy of each treatment option along with the percentage of patients on each therapy. He also speaks about newer drugs replacing the currently marketed treatments, and on the pipeline therapies that are showing promise. We also gain an insight into the world of biosimilars and their uptake in clinical practice. 

This interview was conducted on 28 June 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.